Astellas Launches A New Mobile Application For RNI

Astellas Pharma US, Inc. announced that it has launched a new application for smartphones. The application is the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging (RNI). It aims to allow doctors to review the published criteria used to determine a patient’s need to undergo RNI procedure. The recently alunched application can be downloaded for free, and it works on several platforms such as BlackBerry®, Android™, and iPhone®. The data included in the Appropriate Use Criteria (AUC) for RNI was taken from the ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging (RNI), which was published back in 2009.